The home diagnostics market has seen significant growth over the past few years, reinforced by the COVID-19 pandemic where many were encouraged to test at home for symptoms. Rachel Chapman, Owen Mumford discusses what this means for the sector.
According to the Recall Index by Sedgewick, medical device recalls have reached a record number over the last three years, with safety issues being the top reason. Chris Johnson, managing director at specialist bearing supplier SMB Bearings explains.
After Stratasys announced their collaboration with CollPlant on the development of a solution to bio-fabrication human tissues and organs, Medical Plastics News spoke to Erez Ben Zvi, vice president medical at Stratasys to find out more.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, chair of the Urology Trade Association, a trustee of the Institute of Medical Ethics and a governor of the Anscombe Bioethics Centre, updates readers on Labour’s vision for t
With the injectable drug delivery device market predicted to grow from $39.93 billion in 2022 to $43.54 billion in 2023, manufacturers must ensure continuity of supply for existing devices, John Swift, head of supply chain, Owen Mumford discusses.
Renewable and recycled drop-in solutions enable the production of more sustainable plastics for various applications, including sensitive medical ones.
Over the past 16 years Wideblue has worked with scores of medical device manufacturers on helping them bring their innovations to market. During this time two things have stood out — the importance of prototyping and testing.
Juha Saily, regional development manager, Helmee Imaging, highlights how new vision technology enables automated in-process inspection of medical devices with high gloss, specular and clear surfaces.
